These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8831062)

  • 41. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5.
    Shi W; Yang J; Li S; Shan X; Liu X; Hua H; Zhao C; Feng Z; Cai Z; Zhang L; Zhou D
    Oncotarget; 2015 Nov; 6(37):40172-85. PubMed ID: 26474386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-137 promoter methylation in oral lichen planus and oral squamous cell carcinoma.
    Dang J; Bian YQ; Sun JY; Chen F; Dong GY; Liu Q; Wang XW; Kjems J; Gao S; Wang QT
    J Oral Pathol Med; 2013 Apr; 42(4):315-21. PubMed ID: 23121285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients.
    Eisen D
    J Am Acad Dermatol; 2002 Feb; 46(2):207-14. PubMed ID: 11807431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Premalignant nature of oral lichen planus.
    Laeijendecker R; van Joost T; Kuizinga MC; Tank B; Neumann HA
    Acta Derm Venereol; 2005; 85(6):516-20. PubMed ID: 16396800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical analysis of the oncoprotein c-erbB-2 expression in oral benign and malignant lesions.
    Wilkman TS; Hietanen JH; Malmström MJ; Konttinen YT
    Int J Oral Maxillofac Surg; 1998 Jun; 27(3):209-12. PubMed ID: 9662015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.
    Ibrahim SO; Vasstrand EN; Liavaag PG; Johannessen AC; Lillehaug JR
    Anticancer Res; 1997; 17(6D):4539-46. PubMed ID: 9494565
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular genetics of premalignant oral lesions.
    Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
    Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant potential of oral lichen planus; a follow-up study of 326 patients.
    Markopoulos AK; Antoniades D; Papanayotou P; Trigonidis G
    Oral Oncol; 1997 Jul; 33(4):263-9. PubMed ID: 9307716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Field cancerization in oral lichen planus.
    Mignogna MD; Fedele S; Lo Russo L; Mignogna C; de Rosa G; Porter SR
    Eur J Surg Oncol; 2007 Apr; 33(3):383-9. PubMed ID: 17084578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potentially Malignant Oral Disorders and Cancer Transformation.
    Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
    Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
    Mattila R; Alanen K; Syrjänen S
    Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular analysis of oral lichen planus. A premalignant lesion?
    Zhang L; Michelsen C; Cheng X; Zeng T; Priddy R; Rosin MP
    Am J Pathol; 1997 Aug; 151(2):323-7. PubMed ID: 9250145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
    Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p53 expression in oral precancer and cancer.
    Rich AM; Kerdpon D; Reade PC
    Aust Dent J; 1999 Jun; 44(2):103-5. PubMed ID: 10452165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allelic imbalance in oral lichen planus and assessment of its classification as a premalignant condition.
    Accurso BT; Warner BM; Knobloch TJ; Weghorst CM; Shumway BS; Allen CM; Kalmar JR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):359-66. PubMed ID: 21764610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinoma in Taiwan.
    Kuo MY; Chang HH; Hahn LJ; Wang JT; Chiang CP
    J Oral Pathol Med; 1995 Jul; 24(6):255-60. PubMed ID: 7562661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neoplastic transformation of oral lichen planus. I: Review of the literature].
    Vescovi P; Manfredi M; Savi A; Bonanini M
    Minerva Stomatol; 2000 May; 49(5):249-55. PubMed ID: 11068422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.